Showing results (71-80 of 142) with videos related to
Sort By:
Pageof 15
Journal of Drugs in Dermatology : JDD|June 5, 2023
The Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and Skincare Recommendations for Pediatric Acne PatientsLawrence A Schachner, Anneke Andriessen, Latanya Benjamin, et al.Journal of Drugs in Dermatology : JDD|October 27, 2018
Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical TrialsAdelaide A Hebert, Nuria Albareda, Theodore Rosen, et al.Pediatric Dermatology|June 21, 2012
Tretinoin microsphere gel 0.04% pump for treating acne vulgaris in preadolescents: a randomized, controlled studyLawrence F Eichenfield, Adelaide A Hebert, Lawrence Schachner, et al.Cutis|August 12, 2022
Assessing Treatment Delays for Vitiligo Patients: A Retrospective Chart ReviewKavina Patel, Fabiana C P S Lopes, Katherine R Sebastian, et al.SICOT-J|April 8, 2017
Bone grafting via reamer-irrigator-aspirator for nonunion of open Gustilo-Anderson type III tibial fractures treated with multiplanar external fixatorNicholas Kusnezov, Gautham Prabhakar, Matthew Dallo, et al.Journal of Drugs in Dermatology : JDD|October 3, 2024
A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel TreatmentLawrence A Schachner, Anneke Andriessen, Mercedes E Gonzalez, et al.The Journal of Clinical and Aesthetic Dermatology|May 31, 2021
Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Preadolescent Patients: A Phase IV, Open-label, 12-week StudyAngela Yen Moore, Edward L Lain, Amy McMichael, et al.Pediatric Dermatology|March 10, 2020
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension studyAdelaide A Hebert, Dee Anna Glaser, Lawrence Green, et al.Dermatology and Therapy|August 11, 2021
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic DermatitisBob Geng, Adelaide A Hebert, Liza Takiya, et al.Journal of Drugs in Dermatology : JDD|January 11, 2024
Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne VulgarisLawrence F Eichenfield, Linda Stein Gold, Jenny Han, et al.Pageof 15